{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T05:18:55Z","timestamp":1768367935675,"version":"3.49.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82260512"],"award-info":[{"award-number":["82260512"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Basic Research Program of Yunnan Province","award":["202201AS070076"],"award-info":[{"award-number":["202201AS070076"]}]},{"name":"Joint Projects of Applied Basic Research of Kunming Medical University and Yunnan Province Department of science and Technology","award":["202101AY070001-016"],"award-info":[{"award-number":["202101AY070001-016"]}]},{"name":"Science and Technology Innovation team of Education Department of Yunnan Province","award":["K1322121"],"award-info":[{"award-number":["K1322121"]}]},{"name":"High-level personnel training program of Yunnan Province","award":["RLMY20200016"],"award-info":[{"award-number":["RLMY20200016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15265-8","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T01:03:51Z","timestamp":1764983031000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Using single-cell and transcriptome data to identify prognostic genes associated with SUMO-ylation and their molecular regulatory mechanisms in breast cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Ying","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenglin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"key":"15265_CR1","doi-asserted-by":"crossref","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","DOI":"10.3322\/caac.21834"},{"key":"15265_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"15265_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. 2022;66:15\u201323.","journal-title":"Breast"},{"key":"15265_CR4","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20211033","volume":"95","author":"L Wilkinson","year":"2022","unstructured":"Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. Br J Radiol. 2022;95:20211033.","journal-title":"Br J Radiol"},{"key":"15265_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-04032-x","volume":"12","author":"C Zarotti","year":"2022","unstructured":"Zarotti C, Papassotiropoulos B, Elfgen C, Dedes K, Vorburger D, Pestalozzi B, et al. Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapy. Sci Rep. 2022;12:91.","journal-title":"Sci Rep"},{"key":"15265_CR6","doi-asserted-by":"crossref","unstructured":"Li J, Wu J, Han J. Analysis of tumor microenvironment heterogeneity among breast cancer subtypes to identify Subtype-Specific signatures. Genes. 2022;14:44.","DOI":"10.3390\/genes14010044"},{"key":"15265_CR7","doi-asserted-by":"crossref","unstructured":"Nemutlu GS, Mercaldo ND, Thayumanavan E, Zhan T, Duggan C, Blauvelt BM et al. Forecasting global progress in breast cancer control in the context of the sustainable development goals. BMJ Global Health. 2025;10:e019497.","DOI":"10.1136\/bmjgh-2025-019497"},{"key":"15265_CR8","doi-asserted-by":"publisher","first-page":"1055855","DOI":"10.3389\/fonc.2022.1055855","volume":"12","author":"J Luo","year":"2022","unstructured":"Luo J, Xiao J, Yang Y, Chen G, Hu D, Zeng J. Strategies for five tumour markers in the screening and diagnosis of female breast cancer. Front Oncol. 2022;12:1055855.","journal-title":"Front Oncol"},{"key":"15265_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-022-02667-2","volume":"20","author":"Y Fang","year":"2022","unstructured":"Fang Y, Liu J, Zhang Q, She C, Zheng R, Zhang R, et al. Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates. World J Surg Oncol. 2022;20:211.","journal-title":"World J Surg Oncol"},{"key":"15265_CR10","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.17768","volume":"12","author":"Y Hao","year":"2024","unstructured":"Hao Y, Gu C, Luo W, Shen J, Xie F, Zhao Y, et al. The role of protein post-translational modifications in prostate cancer. PeerJ. 2024;12:e17768.","journal-title":"PeerJ"},{"key":"15265_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101307","volume":"12","author":"Y Li","year":"2025","unstructured":"Li Y, Wang B, Zheng Y, Kang H, He A, Zhao L, et al. The multifaceted role of post-translational modifications of LSD1 in cellular processes and disease pathogenesis. Genes Dis. 2025;12:101307.","journal-title":"Genes Dis"},{"key":"15265_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh2073","volume":"9","author":"D Salas-Lloret","year":"2023","unstructured":"Salas-Lloret D, Jansen NS, Nagamalleswari E, van der Meulen C, Gracheva E, de Ru AH, et al. SUMO-activated target traps (SATTs) enable the identification of a comprehensive E3-specific SUMO proteome. Sci Adv. 2023;9:eadh2073.","journal-title":"Sci Adv"},{"key":"15265_CR13","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/biof.2055","volume":"50","author":"Y Jiao","year":"2024","unstructured":"Jiao Y, Zhang X, Yang Z. SUMO-specific proteases: senps in oxidative stress-related signaling and diseases. Biofactors. 2024;50:910\u201321.","journal-title":"Biofactors"},{"key":"15265_CR14","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrm.2016.81","volume":"17","author":"IA Hendriks","year":"2016","unstructured":"Hendriks IA, Vertegaal AC. A comprehensive compilation of SUMO proteomics. Nat Rev Mol Cell Biol. 2016;17:581\u201395.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"15265_CR15","doi-asserted-by":"crossref","unstructured":"Jiang K, Yang W, Huang J, Tan X, Liu Y, Tu S et al. SENP1 promotes p27kip1 nuclear export though enhanced sumoylation in cholangiocarcinoma leading to increased cell proliferation and chemoresistance. Int J Mol Med. 2025;56:141.","DOI":"10.3892\/ijmm.2025.5582"},{"key":"15265_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-38197-4","volume":"13","author":"J Wang","year":"2023","unstructured":"Wang J, Cong P, Jin Z, Liu L, Sun D, Zhu W, et al. A novel prognostic signature for hepatocellular carcinoma based on SUMOylation-related genes. Sci Rep. 2023;13:11233.","journal-title":"Sci Rep"},{"key":"15265_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1080\/10409238.2020.1738332","volume":"55","author":"A Rabellino","year":"2020","unstructured":"Rabellino A, Khanna KK. The implication of the sumoylation pathway in breast cancer pathogenesis and treatment. Crit Rev Biochem Mol Biol. 2020;55:54\u201370.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"15265_CR18","doi-asserted-by":"publisher","first-page":"973","DOI":"10.7150\/thno.79688","volume":"13","author":"FL Zhang","year":"2023","unstructured":"Zhang FL, Yang SY, Liao L, Zhang TM, Zhang YL, Hu SY, et al. Dynamic sumoylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer. Theranostics. 2023;13:973\u201390.","journal-title":"Theranostics"},{"key":"15265_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-024-00644-4","volume":"10","author":"RT Powell","year":"2024","unstructured":"Powell RT, Rinkenbaugh AL, Guo L, Cai S, Shao J, Zhou X, et al. Targeting neddylation and sumoylation in chemoresistant triple negative breast cancer. NPJ Breast Cancer. 2024;10:37.","journal-title":"NPJ Breast Cancer"},{"key":"15265_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.659428","volume":"9","author":"S Nadanaka","year":"2021","unstructured":"Nadanaka S, Bai Y, Kitagawa H. Cleavage of syndecan-1 promotes the proliferation of the basal-like breast cancer cell line BT-549 via Akt sumoylation. Front Cell Dev Biol. 2021;9:659428.","journal-title":"Front Cell Dev Biol"},{"key":"15265_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1047367","volume":"13","author":"J Wu","year":"2022","unstructured":"Wu J, Zhang F, Zheng X, Zhang J, Cao P, Sun Z, et al. Identification of renal ischemia reperfusion injury subtypes and predictive strategies for delayed graft function and graft survival based on neutrophil extracellular trap-related genes. Front Immunol. 2022;13:1047367.","journal-title":"Front Immunol"},{"key":"15265_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"key":"15265_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"key":"15265_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija R, Farrell JA, Gennert D, Schier AF, Regev A. Spatial reconstruction of single-cell gene expression data. Nat Biotechnol. 2015;33:495\u2013502.","journal-title":"Nat Biotechnol"},{"key":"15265_CR25","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/brain\/awab446","volume":"145","author":"S Smaji\u0107","year":"2022","unstructured":"Smaji\u0107 S, Prada-Medina CA, Landoulsi Z, Ghelfi J, Delcambre S, Dietrich C, et al. Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. Brain. 2022;145:964\u201378.","journal-title":"Brain"},{"key":"15265_CR26","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020107333","volume":"40","author":"B Pal","year":"2021","unstructured":"Pal B, Chen Y, Vaillant F, Capaldo BD, Joyce R, Song X, et al. A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast. EMBO J. 2021;40:e107333.","journal-title":"EMBO J"},{"key":"15265_CR27","doi-asserted-by":"crossref","unstructured":"Fang Z, Li J, Cao F, Li F. Integration of scRNA-Seq and bulk RNA-Seq reveals molecular characterization of the immune microenvironment in acute pancreatitis. Biomolecules. 2022;13:78.","DOI":"10.3390\/biom13010078"},{"key":"15265_CR28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32:381\u20136.","journal-title":"Nat Biotechnol"},{"key":"15265_CR29","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. Clusterprofiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137.","journal-title":"OMICS"},{"key":"15265_CR30","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1093\/bioinformatics\/btq064","volume":"26","author":"G Yu","year":"2010","unstructured":"Yu G, Li F, Qin Y, Bo X, Wu Y, Wang S. GOsemSim: an R package for measuring semantic similarity among GO terms and gene products. Bioinformatics. 2010;26:976\u20138.","journal-title":"Bioinformatics"},{"key":"15265_CR31","first-page":"1","volume":"11","author":"IS Ramsay","year":"2018","unstructured":"Ramsay IS, Ma S, Fisher M, Loewy RL, Ragland JD, Niendam T, et al. Model selection and prediction of outcomes in recent onset schizophrenia patients who undergo cognitive training. Schizophrenia Research: Cognition. 2018;11:1\u20135.","journal-title":"Schizophrenia Research: Cognition"},{"key":"15265_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-15609-5","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Lu F, Yin Y. Applying logistic LASSO regression for the diagnosis of atypical Crohn\u2019s disease. Sci Rep. 2022;12:11340.","journal-title":"Sci Rep"},{"key":"15265_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.682002","volume":"9","author":"TT Liu","year":"2021","unstructured":"Liu TT, Li R, Huo C, Li JP, Yao J, Ji XL, et al. Identification of CDK2-related immune forecast model and CeRNA in lung adenocarcinoma, a pan-cancer analysis. Front Cell Dev Biol. 2021;9:682002.","journal-title":"Front Cell Dev Biol"},{"key":"15265_CR34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","volume":"56","author":"PJ Heagerty","year":"2000","unstructured":"Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56:337\u201344.","journal-title":"Biometrics"},{"key":"15265_CR35","doi-asserted-by":"crossref","unstructured":"Sachs MC. PlotROC: A tool for plotting ROC curves. J Stat Softw. 2017;79:2.","DOI":"10.18637\/jss.v079.c02"},{"key":"15265_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1025397","volume":"12","author":"HZ Jiang","year":"2022","unstructured":"Jiang HZ, Yang B, Jiang YL, Liu X, Chen DL, Long FX, et al. Development and validation of prognostic models for colon adenocarcinoma based on combined immune-and metabolism-related genes. Front Oncol. 2022;12:1025397.","journal-title":"Front Oncol"},{"key":"15265_CR37","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s10495-023-01868-8","volume":"28","author":"Y Shi","year":"2023","unstructured":"Shi Y, Wang Y, Dong H, Niu K, Zhang W, Feng K, et al. Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy. Apoptosis. 2023;28:1423\u201335.","journal-title":"Apoptosis"},{"key":"15265_CR38","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s13402-024-01005-w","volume":"48","author":"A Mart\u00ednez-L\u00f3pez","year":"2025","unstructured":"Mart\u00ednez-L\u00f3pez A, Infante G, Mendiburu-Eli\u00e7abe M, Machuca A, Ant\u00f3n OM, Gonz\u00e1lez-Fern\u00e1ndez M, et al. Sumoylation regulates the aggressiveness of breast cancer-associated fibroblasts. Cell Oncol. 2025;48:437\u201353.","journal-title":"Cell Oncol"},{"issue":"9","key":"15265_CR39","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1021\/pr500119a","volume":"13","author":"D Subramonian","year":"2014","unstructured":"Subramonian D, Raghunayakula S, Olsen JV, Beningo KA, Paschen W, Zhang XD. Analysis of changes in SUMO-2\/3 modification during breast cancer progression and metastasis. J Proteome Res. 2014;13(9):3905\u201318.","journal-title":"J Proteome Res"},{"key":"15265_CR40","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.3892\/or.2016.5036","volume":"36","author":"Z Wang","year":"2016","unstructured":"Wang Z, Jin J, Zhang J, Wang L, Cao J. Depletion of SENP1 suppresses the proliferation and invasion of triple-negative breast cancer cells. Oncol Rep. 2016;36:2071\u20138.","journal-title":"Oncol Rep"},{"key":"15265_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-018-0037-7","volume":"7","author":"H Chen","year":"2018","unstructured":"Chen H, Xu Z, Li X, Yang Y, Li B, Li Y, et al. \u03b1-catenin sumoylation increases I\u03baB\u03b1 stability and inhibits breast cancer progression. Oncogenesis. 2018;7:28.","journal-title":"Oncogenesis"},{"key":"15265_CR42","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1182\/blood-2014-06-584524","volume":"124","author":"A Hoellein","year":"2014","unstructured":"Hoellein A, Fallahi M, Schoeffmann S, Steidle S, Schaub FX, Rudelius M, et al. Myc-induced sumoylation is a therapeutic vulnerability for B-cell lymphoma. Blood. 2014;124:2081\u201390.","journal-title":"Blood"},{"key":"15265_CR43","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.chembiol.2018.10.026","volume":"26","author":"YJ Li","year":"2019","unstructured":"Li YJ, Du L, Wang J, Vega R, Lee TD, Miao Y, et al. Allosteric Inhibition of Ubiquitin-like Modifications by a Class of Inhibitor of SUMO-Activating Enzyme. Cell Chem biology. 2019;26:278-88e6.","journal-title":"Cell Chem biology"},{"key":"15265_CR44","doi-asserted-by":"publisher","first-page":"C846","DOI":"10.1152\/ajpcell.00290.2021","volume":"321","author":"J Pan","year":"2021","unstructured":"Pan J, Ho M. Role of glypican-1 in regulating multiple cellular signaling pathways. Am J Physiol Cell Physiol. 2021;321:C846-58.","journal-title":"Am J Physiol Cell Physiol"},{"key":"15265_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70212","volume":"13","author":"R Shibata","year":"2024","unstructured":"Shibata R, Konishi H, Arita T, Yamamoto Y, Matsuda H, Yamamoto T, et al. Extracellular glypican-1 affects tumor progression and prognosis in esophageal cancer. Cancer Med. 2024;13:e70212.","journal-title":"Cancer Med"},{"key":"15265_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37616-4","volume":"14","author":"N Li","year":"2023","unstructured":"Li N, Quan A, Li D, Pan J, Ren H, Hoeltzel G, et al. The IgG4 hinge with CD28 transmembrane domain improves V(H)H-based CAR T cells targeting a membrane-distal epitope of GPC1 in pancreatic cancer. Nat Commun. 2023;14:1986.","journal-title":"Nat Commun"},{"key":"15265_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-45832-7","volume":"13","author":"R Cai","year":"2023","unstructured":"Cai R, Tressler CM, Cheng M, Sonkar K, Tan Z, Paidi SK, et al. Primary breast tumor induced extracellular matrix remodeling in premetastatic lungs. Sci Rep. 2023;13:18566.","journal-title":"Sci Rep"},{"key":"15265_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14351","volume":"8","author":"G Huang","year":"2017","unstructured":"Huang G, Ge G, Izzi V, Greenspan DS. \u03b13 chains of type V collagen regulate breast tumour growth via glypican-1. Nat Commun. 2017;8:14351.","journal-title":"Nat Commun"},{"key":"15265_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1025192","volume":"12","author":"T Qin","year":"2022","unstructured":"Qin T, Xiang W, Mao Y, Zhai H, Yang Z, Zhang H. Ncrna-regulated CAPZA1 associated with prognostic and immunological effects across lung adenocarcinoma. Front Oncol. 2022;12:1025192.","journal-title":"Front Oncol"},{"key":"15265_CR50","doi-asserted-by":"publisher","first-page":"18298","DOI":"10.18632\/aging.203276","volume":"13","author":"C Shi","year":"2021","unstructured":"Shi C, Weng M, Zhu H, Guo Y, Xu D, Jin H, et al. NUDCD1 knockdown inhibits the proliferation, migration, and invasion of pancreatic cancer via the EMT process. Aging. 2021;13:18298\u2013309.","journal-title":"Aging"},{"key":"15265_CR51","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.canlet.2008.04.035","volume":"269","author":"Q Wang","year":"2008","unstructured":"Wang Q, Li M, Wang Y, Zhang Y, Jin S, Xie G, et al. RNA interference targeting CML66, a novel tumor antigen, inhibits proliferation, invasion and metastasis of HeLa cells. Cancer Lett. 2008;269:127\u201338.","journal-title":"Cancer Lett"},{"key":"15265_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.106957","volume":"212","author":"Y Chen","year":"2025","unstructured":"Chen Y, Yu Y, Kou J, Qi H, Zhang C, Wang F, et al. Astrocytic AEG-1 drives neuroinflammation and enhances seizure susceptibility. Neurobiol Dis. 2025;212:106957.","journal-title":"Neurobiol Dis"},{"key":"15265_CR53","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/sj.onc.1210713","volume":"27","author":"SG Lee","year":"2008","unstructured":"Lee SG, Su ZZ, Emdad L, Sarkar D, Franke TF, Fisher PB. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene. 2008;27:1114\u201321.","journal-title":"Oncogene"},{"key":"15265_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-869","volume":"14","author":"C Du","year":"2014","unstructured":"Du C, Yi X, Liu W, Han T, Liu Z, Ding Z, et al. MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NF\u03baB-dependent pathway. BMC Cancer. 2014;14:869.","journal-title":"BMC Cancer"},{"key":"15265_CR55","doi-asserted-by":"publisher","first-page":"7762","DOI":"10.1002\/cam4.2659","volume":"8","author":"L Zhao","year":"2019","unstructured":"Zhao L, Chen X, Feng Y, Wang G, Nawaz I, Hu L, et al. Cox7a1 suppresses the viability of human non-small cell lung cancer cells via regulating autophagy. Cancer Med. 2019;8:7762\u201373.","journal-title":"Cancer Med"},{"key":"15265_CR56","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.11.97","volume":"7","author":"Z He","year":"2019","unstructured":"He Z, Wang F, Zhang W, Ding J, Ni S. Comprehensive and integrative analysis identifies COX7A1 as a critical methylation-driven gene in breast invasive carcinoma. Ann Transl Med. 2019;7:682.","journal-title":"Ann Transl Med"},{"key":"15265_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-01783-x","volume":"29","author":"SY Wang","year":"2024","unstructured":"Wang SY, Wang YX, Shen A, Yang XQ, Liang CC, Huang RJ, et al. Construction of a gene model related to the prognosis of patients with gastric cancer receiving immunotherapy and exploration of COX7A1 gene function. Eur J Med Res. 2024;29:180.","journal-title":"Eur J Med Res"},{"key":"15265_CR58","doi-asserted-by":"publisher","first-page":"8249","DOI":"10.1007\/s11033-023-08716-7","volume":"50","author":"S Yu","year":"2023","unstructured":"Yu S, Lv L, Li Y, Ning Q, Liu T, Hu T. Plk3 promotes the proneural-mesenchymal transition in glioblastoma via transcriptional regulation of C5AR1. Mol Biol Rep. 2023;50:8249\u201358.","journal-title":"Mol Biol Rep"},{"key":"15265_CR59","doi-asserted-by":"publisher","first-page":"8995","DOI":"10.1021\/acsomega.3c07271","volume":"9","author":"M Xu","year":"2024","unstructured":"Xu M, Deng X, Xiang N, Zhang Z, Yang M, Liu Q. Plk3 enhances cisplatin sensitivity of nonsmall-cell lung cancer cells through inhibition of the PI3K\/AKT pathway via stabilizing PTEN. ACS Omega. 2024;9:8995\u20139002.","journal-title":"ACS Omega"},{"key":"15265_CR60","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cancergen.2022.09.007","volume":"268\u2013269","author":"W Jiawei","year":"2022","unstructured":"Jiawei W, Xiajun B, Tian S, Xuzheng G, Zhenwang Z. Comprehensive analysis of PLKs expression and prognosis in breast cancer. Cancer Genet. 2022;268\u2013269:83\u201392.","journal-title":"Cancer Genet"},{"key":"15265_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028222","volume":"6","author":"LH Chen","year":"2011","unstructured":"Chen LH, Kuo WH, Tsai MH, Chen PC, Hsiao CK, Chuang EY, et al. Identification of prognostic genes for recurrent risk prediction in triple negative breast cancer patients in Taiwan. PLoS ONE. 2011;6:e28222.","journal-title":"PLoS ONE"},{"key":"15265_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1123776","volume":"13","author":"TC Chan","year":"2023","unstructured":"Chan TC, Shiue YL, Li CF. The biological impacts of CEBPD on urothelial carcinoma development and progression. Front Oncol. 2023;13:1123776.","journal-title":"Front Oncol"},{"key":"15265_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.103983","volume":"185","author":"L Hartl","year":"2023","unstructured":"Hartl L, Duitman J, Bijlsma MF, Spek CA. The dual role of C\/EBP\u03b4 in cancer. Crit Rev Oncol\/Hematol. 2023;185:103983.","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"15265_CR64","doi-asserted-by":"publisher","first-page":"31069","DOI":"10.18632\/oncotarget.5209","volume":"6","author":"YH Wang","year":"2015","unstructured":"Wang YH, Wu WJ, Wang WJ, Huang HY, Li WM, Yeh BW, et al. CEBPD amplification and overexpression in urothelial carcinoma: a driver of tumor metastasis indicating adverse prognosis. Oncotarget. 2015;6:31069\u201384.","journal-title":"Oncotarget"},{"key":"15265_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05788-y","volume":"14","author":"XG Mao","year":"2023","unstructured":"Mao XG, Xue XY, Lv R, Ji A, Shi TY, Chen XY, et al. CEBPD is a master transcriptional factor for hypoxia regulated proteins in glioblastoma and augments hypoxia induced invasion through extracellular matrix-integrin mediated EGFR\/PI3K pathway. Cell Death Dis. 2023;14:269.","journal-title":"Cell Death Dis"},{"key":"15265_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1548726","volume":"12","author":"BX Tian","year":"2025","unstructured":"Tian BX, Yu ZX, Qiu X, Chen LP, Zhuang YL, Chen Q, et al. Development and validation of a 14-CpG DNA methylation signature and drug targets for prognostic prediction in breast cancer. Front Med. 2025;12:1548726.","journal-title":"Front Med"},{"key":"15265_CR67","doi-asserted-by":"publisher","first-page":"5772","DOI":"10.1245\/s10434-022-11911-8","volume":"29","author":"X Huang","year":"2022","unstructured":"Huang X, Luo Z, Liang W, Xie G, Lang X, Gou J, et al. Survival nomogram for young breast cancer patients based on the SEER database and an external validation cohort. Ann Surg Oncol. 2022;29:5772\u201381.","journal-title":"Ann Surg Oncol"},{"key":"15265_CR68","first-page":"131","volume":"22","author":"Y Li","year":"2022","unstructured":"Li Y, Chen D, Xuan H, Dragomir MP, Calin GA, Meng X, et al. Construction and validation of prognostic nomogram for metaplastic breast cancer. Bosnian J Basic Med Sci. 2022;22:131\u20139.","journal-title":"Bosnian J Basic Med Sci"},{"key":"15265_CR69","doi-asserted-by":"crossref","unstructured":"Zare E, Yaghoubi SM, Khoshnazar M, Jafari Dargahlou S, Machhar JS, Zheng Z et al. MicroRNAs in cancer immunology: master regulators of the tumor microenvironment and immune Evasion, with therapeutic potential. Cancers. 2025;17:2172.","DOI":"10.3390\/cancers17132172"},{"key":"15265_CR70","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/bjc.2017.220","volume":"117","author":"TA Barnes","year":"2017","unstructured":"Barnes TA, Amir E. HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer. Br J Cancer. 2017;117:451\u201360.","journal-title":"Br J Cancer"},{"key":"15265_CR71","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.it.2016.09.006","volume":"37","author":"A Gardner","year":"2016","unstructured":"Gardner A, Ruffell B. Dendritic cells and cancer immunity. Trends Immunol. 2016;37:855\u201365.","journal-title":"Trends Immunol"},{"key":"15265_CR72","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1631\/jzus.B2300679","volume":"26","author":"S Yuan","year":"2025","unstructured":"Yuan S, Xia Y, Dai G, Rao S, Hu R, Gao Y, et al. Single-cell and spatial transcriptomic analysis reveals that an immune cell-related signature could predict clinical outcomes for microsatellite-stable colorectal cancer patients receiving immunotherapy. J Zhejiang Univ Sci B. 2025;26:371\u201392.","journal-title":"J Zhejiang Univ Sci B"},{"key":"15265_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.888713","volume":"13","author":"J Gao","year":"2022","unstructured":"Gao J, Liang Y, Wang L. Shaping polarization of tumor-associated macrophages in cancer immunotherapy. Front Immunol. 2022;13:888713.","journal-title":"Front Immunol"},{"key":"15265_CR74","doi-asserted-by":"publisher","first-page":"431","DOI":"10.32604\/or.2024.050794","volume":"33","author":"T Zhu","year":"2025","unstructured":"Zhu T, Zhao C, Gong R, Qian AO, Wang X, Lu F, et al. Comprehensive analysis reveals PLK3 as a promising immune target and prognostic indicator in glioma. Oncol Res. 2025;33:431\u201342.","journal-title":"Oncol Res"},{"key":"15265_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-51536-3","volume":"14","author":"G Ma","year":"2024","unstructured":"Ma G, Wu X, Qi C, Yu X, Zhang F. Development of macrophage-associated genes prognostic signature predicts clinical outcome and immune infiltration for sepsis. Sci Rep. 2024;14:2026.","journal-title":"Sci Rep"},{"key":"15265_CR76","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.ccell.2024.07.007","volume":"42","author":"M Shanley","year":"2024","unstructured":"Shanley M, Daher M, Dou J, Li S, Basar R, Rafei H, et al. Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD. Cancer Cell. 2024;42:1450\u2013e6611.","journal-title":"Cancer Cell"},{"key":"15265_CR77","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/14656566.2017.1309024","volume":"18","author":"G Bronte","year":"2017","unstructured":"Bronte G, Andreis D, Bravaccini S, Maltoni R, Cecconetto L, Schirone A, et al. Sorafenib for the treatment of breast cancer. Expert Opin Pharmacother. 2017;18:621\u201330.","journal-title":"Expert Opin Pharmacother"},{"key":"15265_CR78","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ejmech.2016.09.049","volume":"125","author":"V Asati","year":"2017","unstructured":"Asati V, Mahapatra DK, Bharti SK. K-Ras and its inhibitors towards personalized cancer treatment: pharmacological and structural perspectives. Eur J Med Chem. 2017;125:299\u2013314.","journal-title":"Eur J Med Chem"},{"key":"15265_CR79","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1586\/14737140.6.3.313","volume":"6","author":"RA Mesa","year":"2006","unstructured":"Mesa RA. Tipifarnib: Farnesyl transferase inhibition at a crossroads. Expert Rev Anticancer Ther. 2006;6:313\u20139.","journal-title":"Expert Rev Anticancer Ther"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15265-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15265-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15265-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:03:28Z","timestamp":1768341808000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15265-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15265"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15265-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was sanctioned by the Ethics Committee of The First Affiliated Hospital of Kunming Medical University (2024L144). The informed consent was acquired from all participants. All experiments were conducted in line with the ethical guidelines of the 2013 Declaration of Helsinki. The material was made anonymous at the time of collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}